Cited by 106Smoking Behavior and CessationNicotinic Acetylcholine Receptors StudyTreatment of Major Depression

Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial

McClernon, F. Joseph, Hiott, F. Berry, Westman, Eric C., Rose, Jed E., Levin, Edward D.·2006·Psychopharmacology

Abstract

Rationale Despite established links between nicotine dependence and depression, little research has examined the effects of nicotine on depression symptoms.Objective This study evaluated the acute and chronic effects of transdermal nicotine in nonsmokers with baseline depression symptoms during a 4-week, double-blind, placebo-controlled trial.Methods Nonsmokers with scores >or=10 on the Center for Epidemiological Studies Depression scale (CES-D) were recruited from the community. Mood and cognitive performance were measured at baseline (day 0) and at 1, 8, 21, and 28 days. Participants were randomly assigned to wear a placebo or nicotine patch for 4 weeks (3.5 mg/day during weeks 1 and 4; 7 mg/day during weeks 2 and 3). The final sample consisted of 11 nonsmokers with a mean baseline CES-D score of 27.36 (SD=10.53).Results Salivary nicotine levels indicated the majority of participants were compliant with treatment. Acute nicotine did not alter mood. After adjusting for baseline values, chronic nicotine resulted in a significant decline in CES-D scores at day 8 (3.5 mg/day), but returned to placebo levels by the last visit. This return to baseline levels was coincident with a decrease in nicotine administration from 7 to 3.5 mg/day. A similar trend for improved response inhibition as measured by the Conners Continuous Performance Task was also observed. Reported side effects were infrequent and minimal.Conclusion These findings suggest a role for nicotinic receptor systems in the pathophysiology of depression and that nicotinic compounds should be evaluated for treating depression symptoms.

Integrity signals

Registry

Crossref · 10.1007/s00213-006-0516-y

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Clinical studies have demonstrated an increased rate of smoking in individuals with depression, a tendency for depressive symptoms to develop in the context of smoking cessation, and the capacity for nicotine to improve depressive symptoms, even in non-smokers.

    “Clinical studies have demonstrated an increased rate of smoking in individuals with depression (Diwan et al., 1998), a tendency for depressive symptoms to develop in the context of smoking cessation (Laje et al., 2001), and the capacity for nicotine to improve depressive symptoms, even in non-smokers (McClernon et al., 2006; Salin-Pascual et al., 1996).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
McClernon, F. J., Hiott, F. B., Westman, E. C., Rose, J. E., & Levin, E. D.
Affiliations
  • Duke University (US)
  • Duke Medical Center (US)
Corresponding author
McClernon, F. Joseph
Venue
Psychopharmacology
Published
2006-09-15
Volume
189
Issue
1
Pages
125-133
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W1978775632
Cited by
106
References
60
Citations by year
2026: 2 · 2025: 4 · 2024: 1 · 2023: 7 · 2022: 3 · 2021: 6 · 2020: 3 · 2019: 3 · 2018: 8 · 2017: 4 · 2016: 2 · 2015: 7 · 2014: 6 · 2013: 4 · 2012: 7
FWCI
5.97
Type
journal article
Language
en
Open access
closed
Locations
  • Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Alliance for Research on Schizophrenia and Depression
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
transdermal nicotine, nicotine patch, depressive symptoms, non-smokers, nicotinic acetylcholine receptors, mood, response inhibition, cognitive performance, nicotine dependence
MeSH terms
Administration, Cutaneous, Adult, Affect, Analysis of Variance, Antidepressive Agents, Cognition, Depression, Double-Blind Method, Drug Administration Schedule, Female, Humans, Male, Nicotine, Psychiatric Status Rating Scales, Saliva, Severity of Illness Index, Time Factors, Treatment Outcome, Cross-Over Studies, Nicotinic Agonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review